Results 221 to 230 of about 217,258 (295)
The c-Abl inhibitor, Nilotinib, protects dopaminergic neurons in a preclinical animal model of Parkinson's disease [PDF]
Senthilkumar S. Karuppagounder +5 more
openalex +1 more source
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 24, Issue 2, Page 256-258, February 2026.
Farzan Solimani +9 more
wiley +1 more source
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 24, Issue 2, Page 256-259, February 2026.
Farzan Solimani +9 more
wiley +1 more source
EPH receptor B2 (EPHB2); ABL tyrosine kinase (ABL; ABL1; c-ABL) [PDF]
openaire +1 more source
Potential signaling pathways, biomarkers, natural drugs, and chronic myeloid leukemia therapeutics. [PDF]
Alqahtani S.
europepmc +1 more source
The Src/c-Abl pathway is a potential therapeutic target in amyotrophic lateral sclerosis
Keiko Imamura +35 more
openalex +2 more sources
ABL tyrosine kinase (ABL; ABL1; c-ABL); tumor protein p63 (TP63; p63) [PDF]
openaire +1 more source
Infection and herbicide exposure implicate c-Abl kinase in α-Synuclein Ser129 phosphorylation. [PDF]
Ehsani M +10 more
europepmc +1 more source

